Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Brosius

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Renal Physiology|April 9, 2010
Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosisYouli Wang, Kathleen Heilig, Thomas Saunders, et al.
The American Journal of Pathology|October 28, 2003
Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stressCharles Heilig, Frank Brosius, Brian Siu, et al.
Neurobiology of Disease|September 7, 2007
Mouse models of diabetic neuropathyKelli A Sullivan, John M Hayes, Timothy D Wiggin, et al.
Diabetes Research and Clinical Practice|February 29, 2020
Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
Diabetes Technology & Therapeutics|September 9, 2020
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney DiseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 6, 2018
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKDCourtney Tuegel, Ronit Katz, Mariam Alam, et al.
Diabetes Research and Clinical Practice|May 27, 2021
Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020Nikolaus Marx, Lars Ryden, Frank Brosius, et al.
Journal of Diabetes Science and Technology|May 9, 2022
Guideline Development for Medical Device Technology: Issues for ConsiderationTadej Battelino, Frank Brosius, Antonio Ceriello, et al.
Cardiovascular Diabetology|October 14, 2023
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshopAntonio Ceriello, Helena W Rodbard, Tadej Battelino, et al.
Journal of the American Society of Nephrology : JASN|February 5, 2017
Growth Differentiation Factor-15 and Risk of CKD ProgressionViji Nair, Cassianne Robinson-Cohen, Michelle R Smith, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Renal Physiology|April 9, 2010
Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosisYouli Wang, Kathleen Heilig, Thomas Saunders, et al.
The American Journal of Pathology|October 28, 2003
Implications of glucose transporter protein type 1 (GLUT1)-haplodeficiency in embryonic stem cells for their survival in response to hypoxic stressCharles Heilig, Frank Brosius, Brian Siu, et al.
Neurobiology of Disease|September 7, 2007
Mouse models of diabetic neuropathyKelli A Sullivan, John M Hayes, Timothy D Wiggin, et al.
Diabetes Research and Clinical Practice|February 29, 2020
Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
Diabetes Technology & Therapeutics|September 9, 2020
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney DiseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 6, 2018
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKDCourtney Tuegel, Ronit Katz, Mariam Alam, et al.
Diabetes Research and Clinical Practice|May 27, 2021
Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020Nikolaus Marx, Lars Ryden, Frank Brosius, et al.
Journal of Diabetes Science and Technology|May 9, 2022
Guideline Development for Medical Device Technology: Issues for ConsiderationTadej Battelino, Frank Brosius, Antonio Ceriello, et al.
Cardiovascular Diabetology|October 14, 2023
Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshopAntonio Ceriello, Helena W Rodbard, Tadej Battelino, et al.
Journal of the American Society of Nephrology : JASN|February 5, 2017
Growth Differentiation Factor-15 and Risk of CKD ProgressionViji Nair, Cassianne Robinson-Cohen, Michelle R Smith, et al.
Pageof 2